{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:29:07Z","timestamp":1775017747438,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201704030037"],"award-info":[{"award-number":["201704030037"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2015A030302018"],"award-info":[{"award-number":["2015A030302018"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell line models are essential tools to study the molecular mechanisms underlying tumor initiation and progression. There are limited treatment options for penile squamous cell carcinoma (PSCC), accounting for 1\u20132% of male tumors in developing countries, and limited progress in preclinical research in PSCC due to lacking available models with identified genomic characteristics. Here, biological and molecular characteristics and whole-genomic alterations were analyzed in a panel of PSCC cell lines newly established in our laboratory. These cell lines were all human papillomavirus (HPV)-negative, epithelial-like, immortalized, and tumorigenic in nude mice, whereas they displayed different proliferation, migration and invasion capacities in vitro, and tumorigenic ability in nude mice. They were all cisplatin sensitive, anti-EGFR therapy resistant, and androgen irresponsive. Whole-genomic sequecing analysis revealed that transition mutations (C:G&gt;T:A and T:A&gt;C:G) were the most common substitution types in these cell lines, whereas <jats:italic>ERCC5<\/jats:italic>, <jats:italic>TP53<\/jats:italic>, <jats:italic>PTH1<\/jats:italic>, <jats:italic>CLTCL1<\/jats:italic>, <jats:italic>NOTCH2<\/jats:italic>, <jats:italic>MAP2K3<\/jats:italic>, <jats:italic>CDK11A\/B<\/jats:italic>, <jats:italic>USP6<\/jats:italic>, <jats:italic>ADCH5<\/jats:italic>, <jats:italic>BCLAF1<\/jats:italic>, <jats:italic>CDKN2A<\/jats:italic>, <jats:italic>FANCD2<\/jats:italic>, <jats:italic>HRAS<\/jats:italic>, and <jats:italic>NOTCH1<\/jats:italic> were the most frequently altered genes. Amplifications of <jats:italic>MYC<\/jats:italic>, <jats:italic>PLAG1<\/jats:italic>, <jats:italic>NCOA2<\/jats:italic>, <jats:italic>RUNX1T1<\/jats:italic>, <jats:italic>COX6C<\/jats:italic>, and <jats:italic>EGFR<\/jats:italic> and losses of <jats:italic>FBXW7<\/jats:italic>, <jats:italic>TET2<\/jats:italic>, <jats:italic>XPC<\/jats:italic>, and <jats:italic>FANCE<\/jats:italic> were frequently observed in cell lines. The exomic variations between cell lines and their corresponding cancer tissues were highly consistent. Genetic variations were mainly involved in the MAPK, Jak-STAT, TGF-beta, Notch, and apoptosis signaling pathways. Conclusively, these panel of PSCC cell lines established in our laboratory harbor some common or specific biological characteristics and genomic variations, and they may serve as optimal models to investigate the molecular mechanisms underlying the progression, metastasis, relapses, and treatment resistance of PSCC and to develop effective treatment strategy.<\/jats:p>","DOI":"10.1038\/s41419-018-0736-1","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T09:09:22Z","timestamp":1528362562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines"],"prefix":"10.1038","volume":"9","author":[{"given":"Qiang-hua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang-zhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zai-shang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo-wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-ke","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-0177","authenticated-orcid":false,"given":"Ran-yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"736_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.urology.2010.03.003","volume":"76","author":"MR Pow-Sang","year":"2010","unstructured":"Pow-Sang, M. R., Ferreira, U., Pow-Sang, J. M., Nardi, A. C. & Destefano, V. Epidemiology and natural history of penile cancer. Urology 76, S2\u2013S6 (2010).","journal-title":"Urology"},{"key":"736_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg, O. W. et al. EAU guidelines on penile cancer: 2014 update. Eur. Urol. 67, 142\u2013150 (2015).","journal-title":"Eur. Urol."},{"key":"736_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"736_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5732\/cjc.013.10176","volume":"33","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery. Chin. J. Cancer 33, 249\u2013255 (2014).","journal-title":"Chin. J. Cancer"},{"key":"736_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.20414","volume":"93","author":"D Pandey","year":"2006","unstructured":"Pandey, D., Mahajan, V. & Kannan, R. R. Prognostic factors in node-positive carcinoma of the penis. J. Surg. Oncol. 93, 133\u2013138 (2006).","journal-title":"J. Surg. Oncol."},{"key":"736_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","volume":"5","author":"S Misra","year":"2004","unstructured":"Misra, S., Chaturvedi, A. & Misra, N. C. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 5, 240\u2013247 (2004).","journal-title":"Lancet Oncol."},{"key":"736_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1634\/theoncologist.2015-0241","volume":"21","author":"SM Ali","year":"2016","unstructured":"Ali, S. M. et al. Comprehensive genomic profiling of advanced penile carcinoma suggests a high frequency of clinically relevant genomic alterations. Oncologist 21, 33\u201339 (2016).","journal-title":"Oncologist"},{"key":"736_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/gcc.22274","volume":"54","author":"C Ferrandiz-Pulido","year":"2015","unstructured":"Ferrandiz-Pulido, C. et al. Identification of somatic gene mutations in penile squamous cell carcinoma. Genes Chromosomes Cancer 54, 629\u2013637 (2015).","journal-title":"Genes Chromosomes Cancer"},{"key":"736_CR9","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res. 75, 5219\u20135227 (2015).","journal-title":"Cancer Res."},{"key":"736_CR10","first-page":"373","volume":"29","author":"S Ishikawa","year":"1983","unstructured":"Ishikawa, S., Kanoh, S. & Nemoto, S. Establishment of a cell line (TSUS-1) derived from a human squamous cell carcinoma of the penis. Hinyokika Kiyo 29, 373\u2013376 (1983).","journal-title":"Hinyokika Kiyo"},{"key":"736_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1620\/tjem.88.9","volume":"88","author":"I Yamane","year":"1966","unstructured":"Yamane, I. & Tsuda, T. Establishment of a cell line in vitro from the lesion of a clinical case of penis cancroid. Tohoku J. Exp. Med. 88, 9\u201320 (1966).","journal-title":"Tohoku J. Exp. Med."},{"key":"736_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2302\/kjm.38.277","volume":"38","author":"T Tsukamoto","year":"1989","unstructured":"Tsukamoto, T. Establishment and characterization of a cell line (KU-8) from squamous cell carcinoma of the penis. Keio J. Med. 38, 277\u2013293 (1989).","journal-title":"Keio J. Med."},{"key":"736_CR13","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.juro.2012.01.035","volume":"187","author":"CM Naumann","year":"2012","unstructured":"Naumann, C. M. et al. Establishment and characterization of primary cell lines of squamous cell carcinoma of the penis and its metastasis. J. Urol. 187, 2236\u20132242 (2012).","journal-title":"J. Urol."},{"key":"736_CR14","doi-asserted-by":"publisher","first-page":"11375","DOI":"10.1007\/s13277-016-4951-z","volume":"37","author":"JJ Munoz","year":"2016","unstructured":"Munoz, J. J. et al. A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma. Tumour Biol. 37, 11375\u201311384 (2016).","journal-title":"Tumour Biol."},{"key":"736_CR15","doi-asserted-by":"crossref","first-page":"51687","DOI":"10.18632\/oncotarget.10098","volume":"7","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis. Oncotarget 7, 51687\u201351698 (2016).","journal-title":"Oncotarget"},{"key":"736_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.eururo.2015.12.007","volume":"69","author":"L Alemany","year":"2016","unstructured":"Alemany, L. et al. Role of human papillomavirus in penile carcinomas worldwide. Eur. Urol. 69, 953\u2013961 (2016).","journal-title":"Eur. Urol."},{"key":"736_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/onc.2016.172","volume":"36","author":"ML Nickerson","year":"2017","unstructured":"Nickerson, M. L. et al. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. Oncogene 36, 35\u201346 (2017).","journal-title":"Oncogene"},{"key":"736_CR18","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1158\/0008-5472.CAN-14-0013","volume":"74","author":"D Mouradov","year":"2014","unstructured":"Mouradov, D. et al. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res. 74, 3238\u20133247 (2014).","journal-title":"Cancer Res."},{"key":"736_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).","journal-title":"Nat. Commun."},{"key":"736_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570\u2013575 (2012).","journal-title":"Nature"},{"key":"736_CR21","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","volume":"76","author":"A Feber","year":"2016","unstructured":"Feber, A. et al. CSN1 somatic mutations in penile squamous cell carcinoma. Cancer Res. 76, 4720\u20134727 (2016).","journal-title":"Cancer Res."},{"key":"736_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"736_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1200\/JCO.1998.16.3.1197","volume":"16","author":"WH Liggett Jr","year":"1998","unstructured":"Liggett, W. H. Jr & Sidransky, D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16, 1197\u20131206 (1998).","journal-title":"J. Clin. Oncol."},{"key":"736_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.eururo.2014.06.050","volume":"67","author":"PH Kim","year":"2015","unstructured":"Kim, P. H. et al. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder. Eur. Urol. 67, 198\u2013201 (2015).","journal-title":"Eur. Urol."},{"key":"736_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2641","volume":"15","author":"PA Muller","year":"2013","unstructured":"Muller, P. A. & Vousden, K. H. p53 mutations in cancer. Nat. Cell Biol. 15, 2\u20138 (2013).","journal-title":"Nat. Cell Biol."},{"key":"736_CR26","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L. & Dang, C. V. MYC, metabolism, and cancer. Cancer Discov. 5, 1024\u20131039 (2015).","journal-title":"Cancer Discov."},{"key":"736_CR27","unstructured":"Zargar-Shoshtari, K., Sharma, P. & Spiess, P. E. Insight into novel biomarkers in penile cancer: redefining the present and future treatment paradigm? Urol. Oncol. pii: S1078-1439(17)30547-1; doi:10.1016\/j.urolonc.2017.10.010; e-pub ahead of print 2 November 2017."},{"key":"736_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","volume":"14","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari, K. et al. Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort. Clin. Genitourin. Cancer 14, 346\u2013351 (2016).","journal-title":"Clin. Genitourin. Cancer"},{"key":"736_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","volume":"387","author":"G Attard","year":"2016","unstructured":"Attard, G. et al. Prostate cancer. Lancet 387, 70\u201382 (2016).","journal-title":"Lancet"},{"key":"736_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06659-1","volume":"7","author":"FA Marchi","year":"2017","unstructured":"Marchi, F. A. et al. Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma. Sci. Rep. 7, 6707 (2017).","journal-title":"Sci. Rep."},{"key":"736_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","volume":"21","author":"A Feber","year":"2015","unstructured":"Feber, A. et al. Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin. Cancer Res. 21, 1196\u20131206 (2015).","journal-title":"Clin. Cancer Res."},{"key":"736_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","volume":"55","author":"G Pizzocaro","year":"2009","unstructured":"Pizzocaro, G., Nicolai, N. & Milani, A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur. Urol. 55, 546\u2013551 (2009).","journal-title":"Eur. Urol."},{"key":"736_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1383-5742(02)00009-1","volume":"511","author":"C Bernstein","year":"2002","unstructured":"Bernstein, C., Bernstein, H., Payne, C. M. & Garewal, H. DNA repair\/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511, 145\u2013178 (2002).","journal-title":"Mutat. Res."},{"key":"736_CR34","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2174\/0929867324666170124145557","volume":"24","author":"J Blasiak","year":"2017","unstructured":"Blasiak, J. DNA-damaging anticancer drugs\u2014a perspective for DNA repair- oriented therapy. Curr. Med. Chem. 24, 1488\u20131503 (2017).","journal-title":"Curr. Med. Chem."},{"key":"736_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.molcel.2015.12.010","volume":"61","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. FBXW7 facilitates nonhomologous end-joining via K63-linked polyubiquitylation of XRCC4. Mol. Cell 61, 419\u2013433 (2016).","journal-title":"Mol. Cell"},{"key":"736_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/bju.12450","volume":"113","author":"BC Carthon","year":"2014","unstructured":"Carthon, B. C., Ng, C. S., Pettaway, C. A. & Pagliaro, L. C. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int. 113, 871\u2013877 (2014).","journal-title":"BJU Int."},{"key":"736_CR37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/CAD.0b013e32834a149c","volume":"22","author":"X Wei","year":"2011","unstructured":"Wei, X. Mechanism of EGER-related cancer drug resistance. Anticancer Drugs 22, 963\u2013970 (2011).","journal-title":"Anticancer Drugs"},{"key":"736_CR38","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1158\/1078-0432.CCR-13-2721","volume":"20","author":"T Rampias","year":"2014","unstructured":"Rampias, T. et al. RAS\/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma. Clin. Cancer Res. 20, 2933\u20132946 (2014).","journal-title":"Clin. Cancer Res."},{"key":"736_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2013.08.041","volume":"342","author":"CP Wu","year":"2014","unstructured":"Wu, C. P. et al. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain. Cancer Lett. 342, 92\u2013103 (2014).","journal-title":"Cancer Lett."},{"key":"736_CR40","doi-asserted-by":"crossref","first-page":"28478","DOI":"10.18632\/oncotarget.4424","volume":"6","author":"X Fu","year":"2015","unstructured":"Fu, X. et al. High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy. Oncotarget 6, 28478\u201328490 (2015).","journal-title":"Oncotarget"},{"key":"736_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.271","volume":"8","author":"CM Kuang","year":"2017","unstructured":"Kuang, C. M. et al. BST2 confers cisplatin resistance via NF-kappaB signaling in nasopharyngeal cancer. Cell Death Dis. 8, e2874 (2017).","journal-title":"Cell Death Dis."},{"key":"736_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep35427","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology. Sci. Rep. 6, 35427 (2016).","journal-title":"Sci. Rep."},{"key":"736_CR43","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2011.189","volume":"30","author":"RY Liu","year":"2011","unstructured":"Liu, R. Y. et al. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma. Oncogene 30, 4814\u20134823 (2011).","journal-title":"Oncogene"},{"key":"736_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.lfs.2007.05.028","volume":"81","author":"P Zhao","year":"2007","unstructured":"Zhao, P. et al. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth. Life Sci. 81, 695\u2013701 (2007).","journal-title":"Life Sci."},{"key":"736_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0180-0","volume":"36","author":"WY Du","year":"2017","unstructured":"Du, W. Y. et al. The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells. Chin. J. Cancer 36, 11 (2017).","journal-title":"Chin. J. Cancer"},{"key":"736_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-258","volume":"13","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol. Cancer 13, 258 (2014).","journal-title":"Mol. Cancer"},{"key":"736_CR47","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ijc.31169","volume":"142","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer. Int. J. Cancer 142, 1379\u20131391 (2017).","journal-title":"Int. J. Cancer"},{"key":"736_CR48","doi-asserted-by":"publisher","first-page":"e111988","DOI":"10.1371\/journal.pone.0111988","volume":"9","author":"W Deng","year":"2014","unstructured":"Deng, W., Wang, Y., Liu, Z., Cheng, H. & Xue, Y. HemI: a toolkit for illustrating heatmaps. PLoS ONE 9, e111988 (2014).","journal-title":"PLoS ONE"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0736-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0736-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:03:44Z","timestamp":1671537824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0736-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0736-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"2 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board and Human Ethics Committee of SYSUCC, and written informed consent was obtained prior to surgery from each patient. The animal care and experimental protocols were approved by the Guangdong Medical Experimental Animal Care Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"684"}}